# Parabilis Medicines, Inc.: filings

PBLS · Nasdaq · CIK 1657677 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pbls.md) · [Financials](/companies/pbls/financials.md) · [Filings](/companies/pbls/filings.md) · [Insiders](/companies/pbls/insiders.md)

## Reports and events: 11 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 17, 4 17, 8-K 5, D 5, S-1/A 3, D/A 2, SCHEDULE 13G 2, 10-Q 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, FWP 1, S-1 1, S-1MEF 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 16:15 ET | [8-K](/filings/0001193125-26-391952.md) | 7.01 Regulation FD disclosure | 0001193125-26-391952 |
| 2026-09-02 | 16:05 ET | [8-K](/filings/0001193125-26-380171.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-380171 |
| 2026-08-25 | 16:10 ET | [8-K](/filings/0001193125-26-365132.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-365132 |
| 2026-08-13 | 16:08 ET | [10-Q](/filings/0001193125-26-349168.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349168 |
| 2026-08-13 | 07:19 ET | [8-K](/filings/0001193125-26-347869.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347869 |
| 2026-06-18 | 16:09 ET | [SCHEDULE 13D](/filings/0001346824-26-000178.md) | Ownership report, active investor | 0001346824-26-000178 |
| 2026-06-11 | 16:12 ET | [8-K](/filings/0001193125-26-267550.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-267550 |
| 2026-06-09 | 06:09 ET | [S-1/A](/filings/0001193125-26-262880.md) | Registration statement, amended | 0001193125-26-262880 |
| 2026-06-04 | 06:16 ET | [S-1/A](/filings/0001193125-26-256398.md) | Registration statement, amended | 0001193125-26-256398 |
| 2026-05-27 | 16:55 ET | [S-1/A](/filings/0001193125-26-242067.md) | Registration statement, amended | 0001193125-26-242067 |
| 2026-05-19 | 16:53 ET | [S-1](/filings/0001193125-26-230994.md) | Registration statement | 0001193125-26-230994 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.